Atlas Trials

Effect of Cannabinoid Agonist on Gastrointestinal and Colonic Motor Functions in Patients With Irritable Bowel Syndrome (IBS)

Clinical trial NCT01253408 · COMPLETED

Trial details

NCT number
NCT01253408
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Irritable Bowel Syndrome
Start date
2009-09-01
Primary completion
2011-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.